What Every Man Over 72 Should Know About Testosterone Therapy, Hepatic Glucose Production, and Liver Health

If you're a man in your mid-seventies or beyond—and especially if you've been diagnosed with prediabetes, type 2 diabetes, or nonalcoholic fatty liver disease (NAFLD)—you may have heard about testosterone replacement therapy (TRT) as a way to support energy, mood, muscle strength, and sexual health. But what many men don’t realize is that testosterone’s effects on the liver go beyond just hormone balance: it plays a quiet but important role in testosterone therapy hepatic glucose production seniors, influencing how your liver makes and releases sugar into your bloodstream. This matters more than ever as we age—because our livers naturally become less efficient at handling fat and glucose, and conditions like NAFLD affect up to 30% of adults over 65.

It’s easy to assume “more testosterone equals better metabolism” — but that’s not quite right. In fact, two seemingly opposite things happen: testosterone can help lower blood sugar by gently dialing down the liver’s sugar-making enzymes, while also potentially increasing fat buildup in the liver—especially when NAFLD is already present. That duality is why personalized, liver-aware care is essential—not fear-based avoidance, but thoughtful, informed decision-making. You’re not alone in navigating this, and understanding these nuances puts you in a stronger position to partner with your healthcare team.

Why Testosterone Therapy Hepatic Glucose Production Matters for Older Men

Testosterone doesn’t act only on muscles or mood—it circulates widely and binds to receptors in the liver, where it influences key metabolic pathways. One well-documented effect is its ability to suppress gluconeogenic enzymes like phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). These enzymes are the liver’s “sugar factories,” turning amino acids and lactate into glucose—especially overnight or between meals. In men with low testosterone, this process can run slightly unchecked, contributing to higher fasting blood glucose levels. Restoring physiological testosterone levels (not supraphysiological doses) has been associated in studies with modest reductions in fasting glucose—about 8–12 mg/dL on average—particularly in men with baseline hypogonadism and insulin resistance.

However, here’s where caution comes in: testosterone also affects lipid metabolism. In aging men—whose adipose tissue often becomes more metabolically active—exogenous testosterone can shift fat distribution and increase free fatty acid delivery to the liver. When NAFLD is already present, even modest increases in hepatic fat can worsen inflammation and impair insulin signaling, counteracting some of the glucose-lowering benefits. Think of it like tuning a piano: the same note (testosterone) can harmonize or clash, depending on the instrument’s condition (your liver health).

So the real question isn’t “Should I take testosterone?” but rather “How do we optimize testosterone therapy hepatic glucose production seniors while protecting my liver?” That answer starts with measurement—not assumptions.

How to Safely Assess and Monitor Liver and Glucose Response

Before starting TRT—and regularly during treatment—liver health must be assessed thoughtfully. Standard blood tests offer valuable clues:

• ALT (alanine aminotransferase) and AST (aspartate aminotransferase): Elevated levels suggest liver cell stress. In older men, ALT >35 U/L (for men) or AST >30 U/L may signal early NAFLD progression—even if imaging hasn’t yet shown changes.
• Ferritin and gamma-glutamyl transferase (GGT): Often underused but highly informative. Ferritin >200 ng/mL and GGT >45 U/L together raise concern for hepatic iron overload or oxidative stress, both common in aging livers with fat accumulation.
• HbA1c and fasting insulin: An HbA1c ≥5.7% signals prediabetes; ≥6.5% indicates diabetes. Fasting insulin >10 µU/mL suggests insulin resistance—even if glucose looks normal.

Imaging adds clarity: a simple, non-invasive ultrasound can detect moderate-to-severe steatosis (fatty liver), and newer tools like FibroScan® (transient elastography) estimate liver stiffness and fat content without radiation. For men over 72, guidelines from the Endocrine Society recommend baseline liver assessment before initiating TRT—and repeat testing every 6–12 months if NAFLD is known or suspected.

Who should pay extra attention? Men with any of the following:

• A waist circumference ≥40 inches (102 cm),
• Type 2 diabetes or long-standing prediabetes (≥5 years),
• Known NAFLD/NASH on prior imaging or biopsy,
• History of heavy alcohol use—even if discontinued—or chronic use of medications metabolized by the liver (e.g., statins, certain antidepressants).

These aren’t reasons to avoid TRT—but strong indicators that dosing and monitoring need to be especially precise.

Practical Steps You Can Take Today

You don’t need to wait for your next appointment to support healthy testosterone therapy hepatic glucose production seniors. Small, consistent lifestyle habits make measurable differences—especially for liver and glucose metabolism.

First, prioritize moderate-intensity movement: aim for at least 150 minutes per week of brisk walking, water aerobics, or stationary cycling. Resistance training—just two sessions weekly using light bands or body weight—has been shown in clinical trials to reduce intrahepatic fat by ~15% over six months in older men with NAFLD. Pair that with dietary shifts: emphasize whole foods—vegetables, legumes, berries, nuts, and lean proteins—while limiting added sugars (especially fructose from sweetened beverages) and refined carbohydrates. Even modest weight loss—just 3–5% of body weight—can improve liver enzyme levels and insulin sensitivity.

For self-monitoring, keep a simple log: track daily blood glucose (if prescribed), weekly weight, and notes on energy, sleep quality, and digestion. Many men find it helpful to record meals alongside how they feel 2 hours later—this reveals patterns no lab test can. Also consider timing: taking testosterone gels or injections in the morning aligns best with natural circadian rhythms and may reduce nighttime glucose spikes.

Tracking your blood pressure trends can help you and your doctor make better decisions. Consider keeping a daily log or using a monitoring tool to stay informed.

When to see your doctor sooner rather than later? If you notice persistent fatigue despite adequate rest, unexplained weight gain around your midsection, dark urine, pale stools, or new swelling in your ankles or abdomen—these could signal worsening liver function and deserve prompt evaluation. Likewise, if your fasting glucose rises steadily over three consecutive checks (e.g., from 105 to 125 to 138 mg/dL), it’s time to revisit your plan.

A Reassuring Note as You Move Forward

Navigating hormonal health in your seventies isn’t about chasing youth—it’s about honoring the wisdom your body has gathered over decades and supporting it with gentle, evidence-based care. Testosterone therapy hepatic glucose production seniors is a nuanced topic, but it’s one grounded in science, not speculation. With thoughtful monitoring, realistic expectations, and collaborative care, many men experience meaningful improvements in energy, strength, and metabolic stability—without compromising liver health. If you're unsure, talking to your doctor is always a good idea.

FAQ

#### Does testosterone therapy increase blood sugar in older men with NAFLD?

Not necessarily—and not uniformly. In men with low testosterone and insulin resistance, TRT often leads to modest improvements in fasting glucose and insulin sensitivity. However, if NAFLD is advanced (e.g., with fibrosis or elevated ALT/AST), high-dose or poorly monitored TRT may worsen fat accumulation and blunt those benefits. The key is individualized dosing guided by liver enzymes and glucose trends—not blanket recommendations.

#### How does testosterone therapy affect hepatic glucose production seniors with type 2 diabetes?

Testosterone helps regulate hepatic glucose production by reducing the activity of gluconeogenic enzymes like PEPCK and G6Pase. In older men with type 2 diabetes and documented hypogonadism, clinical trials show average reductions in HbA1c of 0.3–0.5% after 6–12 months of physiological TRT—especially when combined with lifestyle support. But again, benefit depends on baseline liver health and avoiding excessive dosing.

#### Can testosterone therapy worsen NAFLD in men over 70?

It can, particularly at supraphysiological doses or in men with significant visceral fat and preexisting metabolic dysfunction. Studies suggest that while TRT itself doesn’t cause NAFLD, it may accelerate fat deposition in an already vulnerable liver—especially if diet, activity, or insulin resistance aren’t addressed concurrently. Regular liver enzyme checks and dose titration help prevent this.

#### Is liver biopsy necessary before starting testosterone therapy?

No—not routinely. Non-invasive tools like ultrasound, FibroScan®, and blood biomarkers (ALT, AST, GGT, ferritin, CK-18) are typically sufficient for risk stratification in clinical practice. Biopsy remains reserved for cases where imaging and labs suggest possible NASH or fibrosis, and diagnosis would change management.

#### What’s the safest form of testosterone for older men with liver concerns?

There’s no universally “safest” formulation—but transdermal gels and patches tend to produce more stable, physiologic serum levels compared to intramuscular injections, which cause peaks and troughs. Oral testosterone is generally avoided in older adults due to first-pass liver metabolism and higher risk of enzyme elevation. Your provider will weigh absorption, convenience, and your personal health profile—not just theoretical safety.